WAYSTAR HOLDING CORP (WAY) Stock Fundamental Analysis
USA - NASDAQ:WAY - US9467841055 - Common Stock
37.36 USD
-0.99 (-2.58%)
37.36 USD
0 (0%)
Taking everything into account, WAY scores 6 out of 10 in our fundamental rating. WAY was compared to 35 industry peers in the Health Care Technology industry. Both the profitability and the financial health of WAY get a neutral evaluation. Nothing too spectacular is happening here. WAY has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
WAY had positive earnings in the past year.
WAY had a positive operating cash flow in the past year.
1.2 Ratios
WAY has a better Return On Assets (1.84%) than 88.57% of its industry peers.
WAY has a better Return On Equity (2.71%) than 88.57% of its industry peers.
WAY's Return On Invested Capital of 3.67% is fine compared to the rest of the industry. WAY outperforms 80.00% of its industry peers.
WAY had an Average Return On Invested Capital over the past 3 years of 2.09%. This is below the industry average of 6.80%.
The 3 year average ROIC (2.09%) for WAY is below the current ROIC(3.67%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.84% | ||
| ROE | 2.71% | ||
| ROIC | 3.67% |
ROA(3y)-0.88%
ROA(5y)N/A
ROE(3y)-1.85%
ROE(5y)N/A
ROIC(3y)2.09%
ROIC(5y)N/A
1.3 Margins
WAY's Profit Margin of 8.50% is amongst the best of the industry. WAY outperforms 94.29% of its industry peers.
The Operating Margin of WAY (20.80%) is better than 94.29% of its industry peers.
In the last couple of years the Operating Margin of WAY has grown nicely.
The Gross Margin of WAY (67.32%) is better than 68.57% of its industry peers.
In the last couple of years the Gross Margin of WAY has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 20.8% | ||
| PM (TTM) | 8.5% | ||
| GM | 67.32% |
OM growth 3Y7.95%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.38%
GM growth 5YN/A
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so WAY is destroying value.
The number of shares outstanding for WAY has been increased compared to 1 year ago.
Compared to 1 year ago, WAY has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 3.01 indicates that WAY is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.01, WAY is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
WAY has a debt to FCF ratio of 4.45. This is a neutral value as WAY would need 4.45 years to pay back of all of its debts.
WAY has a Debt to FCF ratio (4.45) which is in line with its industry peers.
WAY has a Debt/Equity ratio of 0.39. This is a healthy value indicating a solid balance between debt and equity.
WAY has a worse Debt to Equity ratio (0.39) than 60.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.39 | ||
| Debt/FCF | 4.45 | ||
| Altman-Z | 3.01 |
ROIC/WACC0.39
WACC9.48%
2.3 Liquidity
WAY has a Current Ratio of 3.43. This indicates that WAY is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 3.43, WAY is doing good in the industry, outperforming 80.00% of the companies in the same industry.
A Quick Ratio of 3.43 indicates that WAY has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 3.43, WAY is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.43 | ||
| Quick Ratio | 3.43 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 199.63% over the past year.
The Revenue has grown by 17.14% in the past year. This is quite good.
The Revenue has been growing by 17.71% on average over the past years. This is quite good.
EPS 1Y (TTM)199.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%800%
Revenue 1Y (TTM)17.14%
Revenue growth 3Y17.71%
Revenue growth 5YN/A
Sales Q2Q%15.4%
3.2 Future
WAY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 78.87% yearly.
Based on estimates for the next years, WAY will show a quite strong growth in Revenue. The Revenue will grow by 11.12% on average per year.
EPS Next Y341.92%
EPS Next 2Y122.94%
EPS Next 3Y78.87%
EPS Next 5YN/A
Revenue Next Year11.69%
Revenue Next 2Y10.93%
Revenue Next 3Y11.12%
Revenue Next 5YN/A
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 33.66 indicates a quite expensive valuation of WAY.
80.00% of the companies in the same industry are more expensive than WAY, based on the Price/Earnings ratio.
WAY's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 27.30.
WAY is valuated rather expensively with a Price/Forward Earnings ratio of 23.70.
77.14% of the companies in the same industry are more expensive than WAY, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.73, WAY is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.66 | ||
| Fwd PE | 23.7 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of WAY indicates a somewhat cheap valuation: WAY is cheaper than 77.14% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, WAY is valued cheaper than 85.71% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 23.37 | ||
| EV/EBITDA | 19.6 |
4.3 Compensation for Growth
WAY's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of WAY may justify a higher PE ratio.
WAY's earnings are expected to grow with 78.87% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.1
PEG (5Y)N/A
EPS Next 2Y122.94%
EPS Next 3Y78.87%
5. Dividend
5.1 Amount
No dividends for WAY!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
37.36
-0.99 (-2.58%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners66.37%
Inst Owner Change5.66%
Ins Owners1.29%
Ins Owner Change5.78%
Market Cap6.51B
Analysts85.56
Price Target50.76 (35.87%)
Short Float %4.32%
Short Ratio3.1
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.52%
Min EPS beat(2)-1.27%
Max EPS beat(2)6.31%
EPS beat(4)3
Avg EPS beat(4)34.74%
Min EPS beat(4)-1.27%
Max EPS beat(4)103.96%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)3.16%
Min Revenue beat(2)2.36%
Max Revenue beat(2)3.95%
Revenue beat(4)4
Avg Revenue beat(4)4.17%
Min Revenue beat(4)2.36%
Max Revenue beat(4)6.23%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.96%
PT rev (3m)3.21%
EPS NQ rev (1m)1.14%
EPS NQ rev (3m)5.86%
EPS NY rev (1m)4.24%
EPS NY rev (3m)5.07%
Revenue NQ rev (1m)0.16%
Revenue NQ rev (3m)1.05%
Revenue NY rev (1m)1.64%
Revenue NY rev (3m)2.24%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.66 | ||
| Fwd PE | 23.7 | ||
| P/S | 6.44 | ||
| P/FCF | 23.37 | ||
| P/OCF | 21.37 | ||
| P/B | 2.05 | ||
| P/tB | N/A | ||
| EV/EBITDA | 19.6 |
EPS(TTM)1.11
EY2.97%
EPS(NY)1.58
Fwd EY4.22%
FCF(TTM)1.6
FCFY4.28%
OCF(TTM)1.75
OCFY4.68%
SpS5.8
BVpS18.21
TBVpS-4.76
PEG (NY)0.1
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.84% | ||
| ROE | 2.71% | ||
| ROCE | 4.65% | ||
| ROIC | 3.67% | ||
| ROICexc | 3.97% | ||
| ROICexgc | 91.57% | ||
| OM | 20.8% | ||
| PM (TTM) | 8.5% | ||
| GM | 67.32% | ||
| FCFM | 27.55% |
ROA(3y)-0.88%
ROA(5y)N/A
ROE(3y)-1.85%
ROE(5y)N/A
ROIC(3y)2.09%
ROIC(5y)N/A
ROICexc(3y)2.13%
ROICexc(5y)N/A
ROICexgc(3y)47.51%
ROICexgc(5y)N/A
ROCE(3y)2.64%
ROCE(5y)N/A
ROICexcg growth 3Y7.56%
ROICexcg growth 5YN/A
ROICexc growth 3Y30.65%
ROICexc growth 5YN/A
OM growth 3Y7.95%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.38%
GM growth 5YN/A
F-Score8
Asset Turnover0.22
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.39 | ||
| Debt/FCF | 4.45 | ||
| Debt/EBITDA | 3.27 | ||
| Cap/Depr | 15.78% | ||
| Cap/Sales | 2.57% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 81.15% | ||
| Profit Quality | 324.12% | ||
| Current Ratio | 3.43 | ||
| Quick Ratio | 3.43 | ||
| Altman-Z | 3.01 |
F-Score8
WACC9.48%
ROIC/WACC0.39
Cap/Depr(3y)12.11%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.69%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)199.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%800%
EPS Next Y341.92%
EPS Next 2Y122.94%
EPS Next 3Y78.87%
EPS Next 5YN/A
Revenue 1Y (TTM)17.14%
Revenue growth 3Y17.71%
Revenue growth 5YN/A
Sales Q2Q%15.4%
Revenue Next Year11.69%
Revenue Next 2Y10.93%
Revenue Next 3Y11.12%
Revenue Next 5YN/A
EBIT growth 1Y85.59%
EBIT growth 3Y27.06%
EBIT growth 5YN/A
EBIT Next Year134.34%
EBIT Next 3Y42.19%
EBIT Next 5YN/A
FCF growth 1Y375.9%
FCF growth 3Y15.76%
FCF growth 5YN/A
OCF growth 1Y229.9%
OCF growth 3Y16.85%
OCF growth 5YN/A